Veterinary Biologics Market Size Forecasted To Achieve $18.38 Billion By 2029 With Steady Growth

The Veterinary Biologics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Veterinary Biologics Market Size and Its Estimated Growth Rate?
The market size of veterinary biologics has experienced robust growth in the past few years. The market, which was valued at $12.67 billion in 2024, is projected to expand to $13.65 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.7%. Factors contributing to this growth during the historical period include outbreaks of animal diseases, regulatory backing and standards, the need for food safety, the globalisation of commerce, and the economic importance of livestock.

Anticipations are high for a robust expansion in the veterinary biologics market size in the impending years. An increase to $18.38 billion by 2029 is projected, maintaining a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this projected growth within the forecast period include the advent of new infectious diseases, alterations in climate and disease patterns, precision in livestock farming, the adoption of the one health approach, and a surge in pet ownership trends. Key trends set to dominate the forecast period encompass educational initiatives and training programs, sustainable and eco-friendly biologics, the incorporation of digital health records, an uptick in companion animal biologics, and the implementation of customized, targeted therapies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12366

How Are Emerging Segments Shaping the Veterinary Biologics Market Landscape?
The veterinary biologics market covered in this report is segmented -

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases
3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
4) By Application: Production Animal, Companion Animal

Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines
2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits
3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants
4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums
5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

Which Growth Factors Are Influencing Veterinary Biologics Market Expansion?
The growth of the veterinary biologics market is anticipated to be fueled by the escalating incidence of animal diseases. These diseases encompass various health issues affecting different species of animals. The upsurge in animal diseases necessitates superior diagnosis and treatment, achievable through veterinary biologics that apply immunological techniques to manage such conditions. For instance, the European Centre for Disease Prevention and Control, a Sweden-based health department of the European Union, reported 2,467 avian flu outbreaks in poultry, affecting 48 million birds, in October 2022. They also recorded 187 instances in captive birds. Additionally, the World Health Organization, a specialized Switzerland-based agency of the United Nations, stated in July 2022 that rabies causes 59,000 human deaths annually in over 150 countries, with a massive 95% of these cases occurring in Africa and Asia. Consequently, the rise in animal disease instances is stimulating the expansion of the veterinary biologics sector.

Who Are the Dominant Players Across Different Veterinary Biologics Market Segments?
Major companies operating in the veterinary biologics market include Bayer AG, Eli Lilly & Company, Evonik Industries AG, Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Vetoquinol, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

What Are the Latest Developing Trends in the Veterinary Biologics Market?
Leading operators in the veterinary biologics market are concentrating on the creation of innovative biologics like vaccines to improve animal health and prevent diseases. Vaccines work by encouraging the immune system to detect and combat specific pathogens, thus aiding in the prevention of infectious illnesses by promoting acquired immunity. As an example, Merck Animal Health, an international animal health corporation based in the United States, received approval from the U.S. Department of Agriculture (USDA) for the production and sale of an experimental autogenous vaccine directed at avian metapneumovirus (aMPV) type B, which was launched in August 2024. Created in conjunction with Cambridge Technologies, this vaccine is intended to address the severe respiratory problems in poultry caused by aMPV type B, which has been a significant source of financial loss since the end of 2023. Made in a high-tech facility in Minnesota, the vaccine is an oil and water emulsion formulation created to reduce tissue reactions following the vaccination. This fills a substantial void in the market as there were no commercially available vaccines previously.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Which Geographic Regions Are Expected to Dominate the Veterinary Biologics Market in the Coming Years?
North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Veterinary Biologics Market?
2. What is the CAGR expected in the Veterinary Biologics Market?
3. What Are the Key Innovations Transforming the Veterinary Biologics Industry?
4. Which Region Is Leading the Veterinary Biologics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.